Assessment of hepatic prostaglandin E₂ level in carbamazepine induced liver injury

Bertilsson L, Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamaze-pine-10,11-epoxide. An update. Clin Pharmacokinet 11, 177–198, 1986.10.2165/00003088-198611030-000013524954 Search in Google Scholar

Bjornsson E. Hepatotoxicity associated with antiepileptic drugs. Acta Neurol Scand 118, 281–290, 2008.10.1111/j.1600-0404.2008.01009.x18341684 Search in Google Scholar

Casado M, Molla B, Roy R, Fernandez-Martinez A, Cucarella C, Mayoral R, Bosca L, Martin-Sanz P. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes. Hepatology 45, 631–638, 2007.10.1002/hep.2155617326157 Search in Google Scholar

Cavar I, Kelava T, Vukojevic K, Saraga-Babic M, Culo F. The role of prostaglandin E2 in acute acetaminophen hepatotoxicity in mice. Histol Histopathol 25, 819–830, 2010. Search in Google Scholar

Dawson W, Jessup SJ, McDonald-Gibson W, Ramwell PW, Shaw JE. Prostaglandin uptake and metabolism by the perfused rat liver. Br J Pharmacol 39, 585–598, 1970.10.1111/j.1476-5381.1970.tb10366.x17026175472205 Search in Google Scholar

Ekor M, Odewabi AO, Kale OE, Adesanoye OA, Bamidele TO. Celecoxib, a selective cyclooxygenase-2 inhibitor, lowers plasma cholesterol and attenuates hepatic lipid peroxidation during carbon-tetrachloride-associated hepatotoxicity in rats. Drug Chem Toxicol 36, 1–8, 2013.10.3109/01480545.2011.64238022168377 Search in Google Scholar

Ghelardoni S, Tomita YA, Bell JM, Rapoport SI, Bosetti F. Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol Psychiatry 56, 248–254, 2004.10.1016/j.biopsych.2004.05.01215312812 Search in Google Scholar

Gose T, Nakanishi T, Kamo S, Shimada H, Otake K, Tamai I. Prostaglandin transporter (OATP2A1/SLCO2A1) contributes to local disposition of eicosapentaenoic acid-derived PGE3. Prostaglandins Other Lipid Mediat 122, 10–17, 2016.10.1016/j.prostaglandins.2015.12.00326692285 Search in Google Scholar

Higuchi S, Yano A, Takai S, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Metabolic activation and inflammation reactions involved in carbamazepine-induced liver injury. Toxicol Sci 130, 4–16, 2012.10.1093/toxsci/kfs22222790970 Search in Google Scholar

Hughes D, Otani T, Yang P, Newman RA, Yantiss RK, Altorki NK, Port JL, Yan M, Markowitz SD, Mazumdar M, Tai HH, Subbaramaiah K, Dannenberg AJ. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Cancer Prev Res (Phila) 1, 241–249, 2008.10.1158/1940-6207.CAPR-08-0055272056919138967 Search in Google Scholar

Iida A, Sasaki E, Yano A, Tsuneyama K, Fukami T, Nakajima M, Yokoi T. Carbamazepine-induced liver injury requires CYP3A-mediated metabolism and glutathione depletion in rats. Drug Metab Dispos 43, 958–968, 2015.10.1124/dmd.115.06337025870103 Search in Google Scholar

Ivanov AI, Scheck AC, Romanovsky AA. Expression of genes controlling transport and catabolism of prostaglandin E2 in lipopolysaccharide fever. Am J Physiol Regul Integr Comp Physiol 284, R698–R706, 2003.10.1152/ajpregu.00570.2002 Search in Google Scholar

Kasai T, Nakanishi T, Ohno Y, Shimada H, Nakamura Y, Arakawa H, Tamai I. Role of OATP2A1 in PGE(2) secretion from human colorectal cancer cells via exocytosis in response to oxidative stress. Exp Cell Res 341, 123–131, 2016.10.1016/j.yexcr.2016.02.002 Search in Google Scholar

Kuzumoto Y, Sho M, Ikeda N, Hamada K, Mizuno T, Akashi S, Tsurui Y, Kashizuka H, Nomi T, Kubo A, Kanehiro H, Nakajima Y. Significance and therapeutic potential of prostaglandin E2 receptor in hepatic ischemia/reperfusion injury in mice. Hepatology 42, 608–617, 2005.10.1002/hep.20827 Search in Google Scholar

Lertratanangkoon K, Horning MG. Metabolism of carbamazepine. Drug Metab Dispos 10, 1–10, 1982. Search in Google Scholar

Lu W, Uetrecht JP. Peroxidase-mediated bioactivation of hydroxylated metabolites of carbamazepine and phenytoin. Drug Metab Dispos 36, 1624–1636, 2008.10.1124/dmd.107.019554 Search in Google Scholar

Matsuo M, Ensor CM, Tai HH. Cloning and expression of the cDNA for mouse NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta 1309, 21–24, 1996.10.1016/S0167-4781(96)00123-6 Search in Google Scholar

Nakamura Y, Nakanishi T, Shimada H, Shimizu J, Aotani R, Maruyama S, Higuchi K, Okura T, Deguchi Y, Tamai I. Prostaglandin transporter OATP2A1/SLCO2A1 is essential for body temperature regulation during fever. J Neurosci 38, 5584–5595, 2018.10.1523/JNEUROSCI.3276-17.2018817413129899035 Search in Google Scholar

Nakanishi T, Hasegawa Y, Mimura R, Wakayama T, Uetoko Y, Komori H, Akanuma S, Hosoya K, Tamai I. Pros-taglandin transporter (PGT/SLCO2A1) protects the lung from bleomycin-induced fibrosis. PLoS One 0, e0123895, 2015.10.1371/journal.pone.0123895441448625923111 Search in Google Scholar

Nakanishi T, Ohno Y, Aotani R, Maruyama S, Shimada H, Kamo S, Oshima H, Oshima M, Schuetz JD, Tamai I. A novel role for OATP2A1/SLCO2A1 in a murine model of colon cancer. Sci Rep 7, 16567, 2017.10.1038/s41598-017-16738-y570739429185482 Search in Google Scholar

Nassar A, Sharon-Granit Y, Azab AN. Psychotropic drugs attenuate lipopolysaccharide-induced hypothermia by altering hypothalamic levels of inflammatory mediators in rats. Neurosci Lett 626, 59–67, 2016.10.1016/j.neulet.2016.05.01927181513 Search in Google Scholar

Nishizawa N, Ito Y, Eshima K, Ohkubo H, Kojo Ken, Inoue T, Raouf J, Jakobsson PJ, Uematsu S, Akira S, Narumiya S, Waranabe M, Majima M. Inhibition of microsomal prostaglandin E synthase-1 facilitates liver repair after hepatic injury in mice. J Hepatol 69, 110–120, 2018.10.1016/j.jhep.2018.02.00929458169 Search in Google Scholar

Pirmohamed M, Kitteringham NR, Breckenridge AM, Park BK. Detection of an autoantibody directed against human liver microsomal protein in a patient with carbamazepine hypersensitivity. Br J Clin Pharmacol 33, 183–186, 1992a.10.1111/j.1365-2125.1992.tb04022.x Search in Google Scholar

Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol 43, 1675–1682, 1992b.10.1016/0006-2952(92)90696-G Search in Google Scholar

Reilly TP, Brady JN, Marchick MR, Bourdi M, George JW, Radonovich MF, Pise-Masison CA, Pohl LR. A protective role for cyclooxygenase-2 in drug-induced liver injury in mice. Chem Res Toxicol 14, 1620–1628, 2001.10.1021/tx0155505 Search in Google Scholar

Shimada H, Nakamura Y, Nakanishi T, Tamai I. OATP2A1/SLCO2A1-mediated prostaglandin E2 loading into intracellular acidic compartments of macrophages contributes to exocytotic secretion. Biochem Pharmacol 98, 629–638, 2015.10.1016/j.bcp.2015.10.009 Search in Google Scholar

Shimada H, Hashimoto R, Aoki A, Yamada S, Oba K, Kawase A, Nakanishi T, Iwaki M. The regulatory mechanism involved in the prostaglandin E2 disposition in carbon tetrachloride-induced liver injury. Prostaglandins Leukot Essent Fatty Acids 155, 102081, 2020.10.1016/j.plefa.2020.102081 Search in Google Scholar

Thiel A, Ganesan A, Mrena J, Junnila S, Nykanen A, HemmesA, Tai HH, Monni O, Kokkola A, Haglund C, Petrova TV, Ristimaki A. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res 15, 4572–4580, 2009.10.1158/1078-0432.CCR-08-2518 Search in Google Scholar

Tsujii H, Okamoto Y, Kikuchi E, Matsumoto M, Nakano H. Prostaglandin E2 and rat liver regeneration. Gastroenterology 105, 495–499, 1993.10.1016/0016-5085(93)90725-R Search in Google Scholar

Xiao J, Liong EC, Huang H, Tse WO, Lau KS, Pan J, Nanji AA, Fung ML, Xing F, Tipoe GL. Cyclooxygenase-1 serves a vital hepato-protective function in chemically induced acute liver injury. Toxicol Sci 143, 430–440, 2015.10.1093/toxsci/kfu24425432964 Search in Google Scholar

Zhang Y, Desai A, Yang SY, et al. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Science 348, aaa2340, 2015.10.1126/science.aaa2340448112626068857 Search in Google Scholar

Zidar N, Odar K, Glavac D, Jerse M, Zupanc T, Stajer D. Cyclooxygenase in normal human tissues is COX-1 really a constitutive isoform, and COX-2 an inducible isoform? J Cell Mol Med 13, 3753–3763, 2009.10.1111/j.1582-4934.2008.00430.x451652418657230 Search in Google Scholar